Leveraging cutting edge tools and technology to advance I–O: tools of tomorrow 2023

Advancing immunotherapy and data-driven research

Immuno-Oncology Insights 2023; 4(8), 287–294

DOI: 10.18609/ioi.2023.42

Published: 22 November 2023
Jill O'Donnell-Tormey

Lauren Coyle, Editor, Immuno-Oncology Insights, interviews Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs at the Cancer Research Institute, to discuss the latest developments in data-driven technology for the I-O space.